Positron emission tomography as a method for measuring drug delivery to tumors in vivo: the example of [11C]docetaxel
Systemic anticancer treatments fail in a substantial number of patients. This may be caused by inadequate uptake and penetration of drugs in malignant tumors. Consequently, improvement of drug delivery to solid tumors may enhance its efficacy. Before evaluating strategies to enhance drug uptake in t...
Main Authors: | Astrid eVan Der Veldt, Egbert eSmit, Adriaan Anthonius Lammertsma |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-08-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00208/full |
Similar Items
-
Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene–docetaxel conjugate
by: Jun YJ, et al.
Published: (2017-07-01) -
Synthesis and 11C-Radiolabelling of 2-Carboranyl Benzothiazoles
by: Kiran B. Gona, et al.
Published: (2015-04-01) -
Docetaxel-loaded exosomes for targeting non-small cell lung cancer: preparation and evaluation in vitro and in vivo
by: Ying Wang, et al.
Published: (2021-01-01) -
Polypeptide-Based Molecular Platform and Its Docetaxel/Sulfo-Cy5-Containing Conjugate for Targeted Delivery to Prostate Specific Membrane Antigen
by: Stanislav A. Petrov, et al.
Published: (2020-12-01) -
Systemic Biodistribution and Intravitreal Pharmacokinetic Properties of Bevacizumab, Ranibizumab, and Aflibercept in a Nonhuman Primate Model
by: Christoforidis, John Byron, et al.
Published: (2017)